Invention Grant
- Patent Title: Transdermal delivery formulations
-
Application No.: US18492833Application Date: 2023-10-24
-
Publication No.: US12059493B2Publication Date: 2024-08-13
- Inventor: Joel M. Friedman
- Applicant: Albert Einstein College of Medicine
- Applicant Address: US NY Bronx
- Assignee: Albert Einstein College of Medicine
- Current Assignee: Albert Einstein College of Medicine
- Current Assignee Address: US NY Bronx
- Agency: Fox Rothschild LLP
- The original application number of the division: US17565556 2021.12.30
- Main IPC: A61K31/12
- IPC: A61K31/12 ; A61K9/00 ; A61K9/06 ; A61K31/05 ; A61K31/121 ; A61K31/352 ; A61K31/366 ; A61K31/4375 ; A61K31/593 ; A61K47/10 ; A61K47/12 ; A61P7/00 ; A61P37/06
Abstract:
A transdermal formulation for the delivery of one or more active agents to a subject is provided. The formulation can be applied to the treatment of various diseases or conditions associated with an elevated CD38 level.
Public/Granted literature
- US20240050362A1 TRANSDERMAL DELIVERY FORMULATIONS Public/Granted day:2024-02-15
Information query
